GILD Financial Facts
Provision for income taxes: 237.45MTotal revenues: 2.12B
See Full Income Statement
Total current liabilities: 2.22B
Total liabilities and stockholders' equity: 12.64B
See Full Balance Sheet
Gilead Sciences Inc. (GILD) Earnings
|
Expand Research on GILD
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +6.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/27/22 | Q222 | N/A | $1.51 | N/A | N/A | $5.83B | N/A | N/A | N/A | ||
| 4/28/22 |  |
Q122 | $2.12 | $1.81 | +$0.31 | $6.6B | $6.28B | N/A |  | | Details |
| 2/1/22 | |
Q421 | $0.69 | $1.52 | -$0.83 | $7.2B | $6.51B | N/A | | | Details |
| 10/28/21 | |
Q321 | $2.65 | $1.71 | +$0.94 | $7.4B | $6.18B | N/A | | | Details |
| 7/29/21 | |
Q221 | $1.87 | $1.73 | +$0.14 | $6.2B | $6.07B | N/A | | | Details |
| 4/29/21 | |
Q121 | $2.08 | $2.09 | -$0.01 | $6.4B | $6.74B | N/A | | | Details |
| 2/4/21 | |
Q420 | $2.19 | $2.15 | +$0.04 | $7.42B | $7.33B | N/A | | | Details |
| 10/28/20 | |
Q320 | $2.11 | $1.95 | +$0.16 | $6.6B | $6.39B | N/A | | | Details |
